By utilizing ELISA, MPO: DNA was detected in the patient’s serum, and we also identified that, in comparison with the healthy population, there were greatly increased expression levels of MPO: DNA in the serum of breast cancer patients (Fig. 1A). Here, MPO is linked to breast carcinoma.